CONSTRUCTION, EXPRESSION, AND CHARACTERIZATION OF BANN RBDN331Q IN PICHIA PASTORIS

Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. According to World Health Organization (WHO), more than 775 million COVID-19 cases have been reported as of 28 April 2024, with over 6,8 million of them from Indon...

Full description

Saved in:
Bibliographic Details
Main Author: Kristiadi Susetyo, Epafroditus
Format: Final Project
Language:Indonesia
Subjects:
Online Access:https://digilib.itb.ac.id/gdl/view/81409
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
Description
Summary:Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. According to World Health Organization (WHO), more than 775 million COVID-19 cases have been reported as of 28 April 2024, with over 6,8 million of them from Indonesia. SARS-CoV-2 infection starts with the binding of the receptor-binding domain (RBD) of the viral spike (S) protein with angiotensin-converting enzyme 2 (ACE2) receptor on the cell membrane. The infection can be prevented by vaccination with RBD protein that can induce the production of neutralization antibody. Some researches have shown that RBD multimerization can increase vaccine immunogenicity. One way to achieve multimer formation is by fusing RBD with ?-annulus (Bann) polypeptide from tomato bushy stunt virus (TBSV) capsid. RBD has two glycosylation sites, N331 and N343. N343 glycosylation plays an important role in maintaining the active conformation of RBD, while N331 glycosylation could pose steric hindrance to Bann-RBD multimerization. The purposes of this research are to do site directed mutagenesis (SDM) to produce Bann-RBDN331Q variant, construction of Pichia pastoris X-33 carrying Bann-RBDN331Q-encoding gene, expression of Bann-RBDN331Q encoding gene, and characterization of Bann-RBDN331Q protein. Mutation of N331 encoding codon has been done and verified by nucleotide sequencing. P. pastoris X-33 carrying Bann-RBDN331Q-encoding gene has been constructed and verified by PCR. Expression of Bann-RBDN331Q-encoding gene in P. pastoris was induced by the addition of 2% methanol. SDS-PAGE analysis showed the presence of protein with a molecular mass of around 34 kDa. Characterization with endoglycosidase Hf (Endo Hf) showed that the protein is glycosylated indicated by decrease of molecular mass. Characterization with enzyme-linked immunosorbent assay (ELISA) showed that the produced Bann-RBDN331Q could interact with S1 IgG human monoclonal antibody. The results of this research showed that Bann-RBDN331Q could be a candidate of COVID-19 vaccine